Though lower price cards may help ease the load of superior drug fees from the temporary, they don't handle the systemic difficulties driving up prescription rates within the U.S. Broader plan changes could tackle the foundation will cause of climbing drug rates, for example deficiency of transparency in pricing as well as function of intermediarie